ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.

DYAI Dyadic International Inc

1,43
-0,07 (-4,67%)
04 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Dyadic International Inc DYAI NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
-0,07 -4,67% 1,43 06:00:08
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1,48 1,40 1,4999 1,43 1,50
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
30/4/202422:30GLOBEDyadic to Report First Quarter 2024 Financial Results on..
28/3/202421:00GLOBEDyadic Reports 2023 Full Year Results and Recent Company..
28/3/202413:30GLOBEDyadic Announces Change in Board and Management Leadership..
27/3/202413:30GLOBEDyadic to Attend Industry Events in April
26/3/202413:30GLOBEDyadic Announces Publication of C1 Monoclonal Antibody in..
21/3/202413:30GLOBEDyadic to Attend Future Food Tech Event March 21 – 22, 2024..
14/3/202421:30GLOBEDyadic to Report Full Year 2023 Financial Results and Host..
11/3/202414:57GLOBECORRECTION – Dyadic Announces Closing of Private Placement..
11/3/202413:45EDGAR2Form 8-K - Current report
11/3/202413:30GLOBEDyadic Announces Closing of Private Placement of $6.0..
01/3/202414:30GLOBEDyadic to Attend Industry Events in March
28/2/202414:30GLOBEDyadic Announces Strategic Partnership Agreement to..
21/2/202414:30GLOBEDyadic Advances Collaboration with Israel Institute for..
13/2/202422:41EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202414:30GLOBEDyadic and Cygnus Technologies Announce Partnership To..
06/2/202414:30GLOBEDyadic Announces Research and Development Collaboration..
01/2/202422:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
01/2/202414:30GLOBEDyadic to Attend BIO CEO & Investor Conference and European..
05/1/202402:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202402:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202402:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202402:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202402:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202402:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202402:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202402:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202402:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202414:30GLOBEDyadic to Attend J.P. Morgan 42nd Annual Healthcare..
30/11/202314:30GLOBEDyadic Attends Investor Events in December
29/11/202314:30GLOBEDyadic Announces Top-Line Results from its Successful Phase..
20/11/202314:30GLOBEDyadic’s C1 Platform to be Used to Produce Vaccines..
08/11/202322:09EDGAR2Form 8-K - Current report
08/11/202322:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202322:00GLOBEDyadic Announces Third Quarter 2023 Financial Results and..
30/10/202313:30GLOBEDyadic to Present at Industry Events in November
25/10/202322:30GLOBEDyadic to Report Third Quarter 2023 Financial Results on..
09/10/202314:30GLOBEDyadic Appoints Doug Pace to Its Executive Leadership Team
06/10/202322:20EDGAR2Form 8-K - Current report
06/10/202322:10EDGAR2Form 8-K - Current report
05/10/202314:30GLOBEDyadic’s C1 Platform Selected by the Vaccine and..
29/9/202314:30GLOBEDyadic to Present at Industry and Investor Events in October
26/9/202314:30GLOBEDyadic and bYoRNA Announce a Collaboration Targeting the..
19/9/202314:30EDGAR2Form 8-K - Current report
19/9/202314:00GLOBEDyadic Announces Development and License Agreement to..
12/9/202322:30GLOBEDyadic to Present at BioProcess International
28/8/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
09/8/202322:10EDGAR2Form S-3 - Registration statement under Securities Act of..
09/8/202322:08EDGAR2Form 8-K - Current report
09/8/202322:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Dernières Valeurs Consultées

Delayed Upgrade Clock